We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$12.2B
AUM Growth
+$239M
Cap. Flow
+$414M
Cap. Flow %
3.41%
Top 10 Hldgs %
19.47%
Holding
126
New
9
Increased
77
Reduced
31
Closed
7

Top Buys

Rank Stock Value
1
LW icon
Lamb Weston
LW
+$156M
2
FTV icon
Fortive
FTV
+$73.6M
3
TENB icon
Tenable Holdings
TENB
+$58.7M
4
ROK icon
Rockwell Automation
ROK
+$54.3M
5
WDAY icon
Workday
WDAY
+$50.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.02%
2 Technology 19.78%
3 Industrials 15.51%
4 Consumer Staples 14.41%
5 Financials 14.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYBT icon
101
Stock Yards Bancorp
SYBT
$2.68B
$33.8M 0.28%
921,636
+19,180
+2% +$699K
TRS icon
102
TriMas Corp
TRS
$1.36B
$33.7M 0.28%
1,100,545
+21,160
+2% +$639K
PEN icon
103
Penumbra
PEN
$12.6B
$33M 0.27%
245,370
+57,045
+30% +$8.82M
SAM icon
104
Boston Beer
SAM
$1.93B
$31.2M 0.26%
85,760
-56,865
-40% -$22.3M
AQUA
105
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$25.5M 0.21%
1,500,260
+215,350
+17% +$3.24M
CCF
106
DELISTED
Chase Corporation
CCF
$24.2M 0.2%
221,500
+3,410
+2% +$349K
JJSF icon
107
J&J Snack Foods
JJSF
$1.44B
$24M 0.2%
125,190
-34,660
-22% -$6.29M
TLND
108
DELISTED
Talend S.A. American Depositary Shares
TLND
$22.6M 0.19%
665,575
+11,805
+2% +$438K
CSW
109
CSW Industrials
CSW
$5.11B
$19.2M 0.16%
278,810
+168,040
+152% +$11.6M
INSP icon
110
Inspire Medical Systems
INSP
$1.44B
$18.1M 0.15%
+296,390
New +$19.5M
SUPN icon
111
Supernus Pharmaceuticals
SUPN
$2.65B
$17.2M 0.14%
626,040
-960,085
-61% -$28.4M
ATRC icon
112
AtriCure
ATRC
$2.04B
$16.8M 0.14%
+675,435
New +$19.3M
LDL
113
DELISTED
Lydall, Inc.
LDL
$16.3M 0.13%
652,510
-404,300
-38% -$8.63M
NOVT icon
114
Novanta
NOVT
$4.95B
$12.9M 0.11%
+157,570
New +$12.8M
PLMR icon
115
Palomar
PLMR
$3.61B
$11.3M 0.09%
+286,405
New +$8.94M
NVST icon
116
Envista
NVST
$4.52B
$11.2M 0.09%
+400,000
New +$11.2M
ARCE
117
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$792K 0.01%
15,615
+2,160
+16% +$100K
BABA icon
118
Alibaba
BABA
$279B
$244K ﹤0.01%
1,460
ABEV icon
119
Ambev
ABEV
$48.2B
$63K ﹤0.01%
13,600
GTES icon
120
Gates Industrial Corporation Ltd.
GTES
$6.53B
-5,974,145
Closed -$68.2M
NOAH
121
Noah Holdings
NOAH
$583M
-18,485
Closed -$787K
OMCL icon
122
Omnicell
OMCL
$1.69B
-101,095
Closed -$8.7M
PODD icon
123
Insulet
PODD
$11.5B
-513,060
Closed -$61.2M
VVV icon
124
Valvoline
VVV
$4.9B
-4,256,990
Closed -$83.1M
CVET
125
DELISTED
Covetrus, Inc. Common Stock
CVET
-65,926
Closed -$1.61M

Similar funds

Champlain Investment Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Champlain Investment Partners held 126 positions worth $12.2B, up 2% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners deployed $414M of net new capital in Q3 2019, opening 9 new positions and adding to 77 existing holdings. Its largest new stake was Lamb Weston: 2,269,235 shares worth $165M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was RB Global, an estimated $125M trimmed.

  • Champlain Investment Partners's largest Q3 2019 buy was Lamb Weston: 2,269,235 shares worth $165M.
  • Champlain Investment Partners added most to Fortive in Q3 2019, an estimated $73.6M increase.
  • Champlain Investment Partners's biggest Q3 2019 reduction was RB Global, cutting an estimated $125M.
  • Champlain Investment Partners fully exited Valvoline in Q3 2019, selling an estimated $83.1M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $12.2B portfolio in Q3 2019.
  • Champlain Investment Partners opened 9 new positions and closed 7 in Q3 2019.
  • Champlain Investment Partners's portfolio value rose 2% quarter-over-quarter to $12.2B.

Based on Champlain Investment Partners's 13F filing for Q3 2019, filed 14 Nov 2019.